Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research DUBLIN & PISCATAWAY, N.J.–(BUSINESS

Gene 52

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

BioTech 365

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Antibodies generated by Flow Eighteen38 to be used as research tools by Hubrecht Institute.

Avacta Signs Diagnostic Licensing Deal with Biokit

BioTech 365

Tampa FL Institute of Interpersonal Hypnotherapy Licensed Hypnosis Training

BioTech 365

The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation

Scienmag

Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].

Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer

BioTech 365

GATC Health Licenses Diabetes Platform to GATC DB Care Corp

BioTech 365

GATC Health Licenses Diabetes Platform to GATC DB Care Corp GATC Health Licenses Diabetes Platform to GATC DB Care Corp Dr. Jonathan Lakey to oversee research and product development projects for GATC DB Care IRVINE, Calif.–(BUSINESS

ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement

BioTech 365

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

ERS Genomics signs CRISPR license agreement with Otsuka

Pharma Times

License grants Otsuka access to CRISPR/Cas9 genome editing technology

ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical

BioTech 365

Pfizer and BioNTech start Biologics License Application for COVID-19 vaccine

BioPharma Reporter

Pfizer and BioNTech have started a rolling submission for a Biologics License Application (BLA) in the US for their COVID-19 vaccine. Markets & Regulations

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement

BioTech 365

Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.

BioTech 365

Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A. Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.

Avacta Announces License Agreement With POINT Biopharma Inc.

BioTech 365

Avacta Announces License Agreement With POINT Biopharma Inc. Avacta Announces License Agreement With POINT Biopharma Inc.

ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement

BioTech 365

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

Avacta Group plc Signs License Agreement With Astrea Bioseparations

BioTech 365

How Different Crimes Can Affect Your Nursing License in Georgia

Pharma Mirror

But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.

Orthofix Announces Exclusive US License for IGEA’s Bone and Joint Stimulation Devices

BioTech 365

Orthofix Announces Exclusive US License for IGEA’s Bone and Joint Stimulation Devices Orthofix Announces Exclusive US License for IGEA’s Bone and Joint Stimulation Devices Orthofix to pursue FDA approval of IGEA’s solutions to expand the Company’s US Bone Growth Therapy … Continue reading → Business Wire

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs

BioTech 365

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs SAN CARLOS, Calif.–(BUSINESS

C4X Discovery agrees licensing deal with Sanofi

Pharma Times

Sanofi could pay up to €414m for C4X Discovery’s oral IL-17A inhibitor programme

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Pharma Phorum

ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from UK biotech iosBio. The post Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech appeared first on.

City of Hope Enters Licensing Agreements with CytoImmune Therapeutics Inc. to Develop Portfolio of Chimeric Antigen Receptor-Natural Killer Therapies

BioTech 365

City of Hope Enters Licensing Agreements with CytoImmune Therapeutics Inc. to Develop Portfolio of Chimeric Antigen Receptor-Natural Killer Therapies City of Hope Enters Licensing Agreements with CytoImmune Therapeutics Inc.

Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

BioTech 365

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous Eckert & Ziegler Receives Technetium Generator Licenses for Brazil 12-Apr-2021 / 21:12 CET/CEST Disclosure of an inside information acc.

US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin ‘GC5107’

BioTech 365

US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin ‘GC5107’ US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin ‘GC5107’ – A significant milestone towards entering the world’s largest plasma product marketplace YONGIN, South Korea–(BUSINESS WIRE)–GC … Continue reading → Business Wire

An Opportune Time to Update Medical Licensing

JAMA Internal Medicine

This Viewpoint discusses ways in which state medical licensing regulations can be modified to allow wider adoption of telemedicine by practitioners and to increase access for patients

Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific

BioTech 365

MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimab

Pharma Phorum

There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN®

BioTech 365

DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN® DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN® Nuvothera acquires option to licence rights to develop and commercialise DS Biopharma’s EPADILIN® in the US DS Biopharma … Continue reading → Business Wire

Pure Extracts Submits Application to Health Canada for Sales License

BioTech 365

Pure Extracts Submits Application to Health Canada for Sales License Pure Extracts Submits Application to Health Canada for Sales License VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure … Continue reading → GlobeNewswire

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

BioTech 365

Announces License and Research Agreement with Philips ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022 IRVINE, Calif., ClearPoint Neuro, Inc. 18, 2021 … Continue reading → GlobeNewswire

Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V.

BioTech 365

Enters into License and Development Agreement with Amzell B.V. Enters into License and Development Agreement with Amzell B.V. Amring Pharmaceuticals Inc. Amring Pharmaceuticals Inc. BERWYN, Pa.–(BUSINESS –(BUSINESS WIRE)–Amring Pharmaceuticals Inc.

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration

BioTech 365

UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies

BioTech 365

UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies Non-dilutive capital will support advancement of ADXS-HOT neoantigen program PRINCETON, … Continue reading → GlobeNewswire

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

BioTech 365

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand

BioTech 365

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand PARIS & SOUTH SAN FRANCISCO, Calif.–(BUSINESS

DNA 52

Heritage Cannabis Holdings Subsidiary CannaCure Receives Amended Sales License Allowing for the Sale of Dried Cannabis Products

BioTech 365

Heritage Cannabis Holdings Subsidiary CannaCure Receives Amended Sales License Allowing for the Sale of Dried Cannabis Products Heritage Cannabis Holdings Subsidiary CannaCure Receives Amended Sales License Allowing for the Sale of Dried Cannabis Products TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Sales 52

Takara Bio in stem cell licensing deal aimed at supporting cell-based therapy R&D for diabetes

BioPharma Reporter

Takara Bio Europe has announced a licensing agreement with Denmarkâs PanCryos, a pre-clinical stage biotech company, for its clinical-grade human embryonic stem (hES) cell lines, starting material for cell therapy development.